Login / Signup
Wei Zhong
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Phase Ii
Study Protocol
Childhood Cancer
Squamous Cell Carcinoma
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Funda Meric-Bernstam
,
Emiliano Calvo
,
Keun Seok Lee
,
Victor Moreno
,
Yeon Hee Park
,
Sun Young Rha
,
Pavani Chalasani
,
Wei Zhong
,
Diansong Zhou
,
Steven R Pirie-Shepherd
,
Abraham Cf Leung
,
Curigliano Giuseppe
Safety and Tolerability of a Novel Anti-HER2 Antibody-Drug Conjugate (PF-06804103) in Patients With HER2-Expressing Solid Tumors: A Phase 1 Dose Escalation Study.
Molecular cancer therapeutics
(2023)